Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels), regarding the 2018/2019 annual results. The key points are:
- EPRA Earnings* increased to €72.1 million as of 30 June 2019 (+24 % compared to 30 June 2018) and EPRA Earnings* per share to €3.74 (+15 % compared to 30 June 2018)
- Confirmation of the proposed dividend of €2.80 gross per share (+12 %)
- 100 % pure play investor in European healthcare real estate following the divestment of the hotel portfolio and 75 % of the participation in Immobe NV/SA (apartment portfolio)
- Entry into the UK healthcare real estate market
- Healthcare real estate investments of approx. €910 million carried out and/or announced
- Real estate portfolio* of €2.3 billion as of 30 June 2019 (+33 % increase compared to 30 June 2018)
- 261 healthcare sites comprising more than 19,000 units in four countries:
- €1,028 million in Belgium (79 sites)
- €381 million in Germany (49 sites)
- €336 million in the Netherlands (43 sites)
- €524 million in the United Kingdom (90 sites)
- Pipeline of €428 million in acquisitions, construction and renovation projects
- Rental income increased to €118 million as of 30 June 2019 (+29 % compared to 30 June 2018)
- Weighted average unexpired lease term of 21 years and occupancy rate of 100 %
- Capital increase of €418 million, the largest ever for a Belgian REIT
- Debt-to-assets ratio of 37.2 % as of 30 June 2019
- Forecast for the 2019/2020 financial year: proposed gross dividend of €3.00
Attachments
